Kelly CRISPR & Gene Editing Technology ETF
Kelly CRISPR & Gene Editing Technology ETF
ETF · CA46437W1059 · XDNA (XNAS)
Overview
No Price
n/a

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
- - - - 0,00 % 0,00 % -48,03 %

Firmenprofil zu Kelly CRISPR & Gene Editing Technology ETF ETF

The adviser employs a “passive management” investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.

Unternehmensdaten

Name Kelly CRISPR & Gene Editing Technology ETF
Firma Kelly CRISPR & Gene Editing Technology ETF
Symbol XDNA
Heimatbörse XNAS NASDAQ
ISIN CA46437W1059
Wertpapierart ETF
Sektor Financial Services
Branche Asset Management
Währung USD
Mitarbeiter -
IPO Datum 2022-01-13

Ticker Symbole

Name Symbol
NASDAQ XDNA

Weitere Aktien

Investoren die Kelly CRISPR & Gene Editing Technology ETF die halten, haben auch folgende Aktien im Depot:
Lalique Group SA
Lalique Group SA Aktie
PROSHARES ULTRA CONSUMER GOODS
PROSHARES ULTRA CONSUMER GOODS ETF
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025